검색
IO Biotech Inc
IOBT관심 목록에 추가
0.048USD
0.0000.00%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
366.94K시가총액
손실P/E TTM
자세한 내용은 IO Biotech Inc 회사
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
IO Biotech Inc 정보
종목 코드 IOBT
회사 이름IO Biotech Inc
상장일Nov 05, 2021
CEOZocca (Mai-Britt)
직원 수80
유형Ordinary Share
회계 연도 종료Nov 05
주소Ole Maaloes Veh 3
도시COPENHAGEN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Denmark
우편 번호2200
전화4570702980
웹사이트https://www.iobiotech.com/
종목 코드 IOBT
상장일Nov 05, 2021
CEOZocca (Mai-Britt)
IO Biotech Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
자주 묻는 질문
IO Biotech Inc의 상위 5대 주주는 누구인가요?
IO Biotech Inc의 상위 5대 주주는 다음과 같습니다: Dr. Mai-Britt Zocca, Ph.D.
IO Biotech Inc(IOBT)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, IO Biotech Inc의 주식을 보유한 기관은 총 56곳이며, 이들이 보유한 주식의 총 가치는 약 33.96M로 전체 발행 주식의 47.71%를 차지합니다. 이는 2025Q4 대비 -19145442.00 증가한 수치입니다.